| 曹强,霍彬,霍小东,王金焕,王磊,臧立,侯定坤,王海涛,王俊杰,柴树德.3D打印共面模板辅助CT引导125Ⅰ粒子植入治疗非小细胞肺癌的剂量学研究[J].中华放射医学与防护杂志,2017,37(7):528-532 |
| 3D打印共面模板辅助CT引导125Ⅰ粒子植入治疗非小细胞肺癌的剂量学研究 |
| Dosimetric study of 3D-printing coplanar template combined with CT-guided 125Ⅰ seed implantation for treating non-small cell lung cancer |
| 投稿时间：2017-04-05 |
| DOI：10.3760/cma.j.issn.0254-5098.2017.07.011 |
| 中文关键词: 3D打印 共面模板 徒手 125Ⅰ粒子植入 非小细胞肺癌 |
| 英文关键词:3D-printing Coplanar template Free hand 125Ⅰ seed implantation Non small cell lung cancer |
| 基金项目:国家自然科学基金（81572543）；天津市自然科学基金（15JCYBJC28400） |
| 作者 | 单位 | E-mail | | 曹强 | 300211, 天津医科大学第二医院肿瘤科 | | | 霍彬 | 300211, 天津医科大学第二医院肿瘤科 | | | 霍小东 | 300211, 天津医科大学第二医院肿瘤科 | | | 王金焕 | 300211, 天津医科大学第二医院肿瘤科 | | | 王磊 | 300211, 天津医科大学第二医院肿瘤科 | | | 臧立 | 300211, 天津医科大学第二医院肿瘤科 | | | 侯定坤 | 300211, 天津医科大学第二医院肿瘤科 | | | 王海涛 | 300211, 天津医科大学第二医院肿瘤科 | peterrock2000@126.com | | 王俊杰 | 300211, 天津医科大学第二医院胸外科 | | | 柴树德 | 100191, 北京大学第三医院肿瘤放疗科 | |
|
| 摘要点击次数: 2996 |
| 全文下载次数: 1690 |
| 中文摘要: |
| 目的 探讨3D打印共面模板（3D-print coplanar template，3D-PCT）辅助CT引导 125Ⅰ粒子植入治疗非小细胞肺癌（NSCLC）的安全、有效及对剂量学的可控性。方法 选取2014年5月到2016年11月符合 125Ⅰ粒子植入适应证的NSCLC患者20例，其中3D-PCT辅助CT引导 125Ⅰ粒子植入治疗的患者10例（3D组），CT引导徒手穿刺 125Ⅰ粒子植入治疗的患者10例（徒手组），术前2 d内行CT定位扫描，得出医学数字成像和通信（digital imaging and communications in medicine，DICOM）数据，输入治疗计划系统（brachytherapy treatment planning system，BTPS），行术前预计划。术后即刻行胸部CT扫描，术后质量验证。对比两组术前、术后剂量学参数，包括90%和100%的靶区体积所占的剂量D90和D100、100%和150%的处方剂量所占的靶区体积百分比V100和V150、适形指数（CI）、靶区外体积指数（EI）、均匀性指数（HI）。结果 3D组术前与术后剂量学参数V150差异有统计学意义（t=-2.916，P< 0.05），其他剂量学参数差异无统计学意义（P> 0.05）。徒手组术前与术后剂量学参数，包括粒子数、V100、EI、HI差异有统计学意义（t=-2.516、2.492、4.725、7.258，P< 0.05），其他剂量学参数差异无统计学意义（P> 0.05）。3D组术后剂量学参数和徒手组术后剂量学参数行单样本t检验，其中V100、CI、EI、HI、剂量误差率差异有统计学意义（t=2.598、2.278、4.637、4.616、-4.785，P< 0.05），两组术后V150差异无统计学意义（P> 0.05）。结论 3D-PCT辅助CT引导125Ⅰ近距离放射性粒子植入治疗NSCLC安全可行，剂量学可控，且在粒子空间分布方面较徒手穿刺具有一定优势。 |
| 英文摘要: |
| Objective To explore the safety, effectivity and dosimetric continence of 3D-printing coplanar template(3D-PCT)combined with CT-guided 125Ⅰ seed implantation in the treatment of non-small cell lung cancer(NSCLC). Methods From May 2014 to November 2016, a total of 20 NSCLC patients who were suitable for 125Ⅰ seed implantation were recruited in this study. Of all the patients, 10 received 125Ⅰ seed implantation treatment by CT-guided combined with 3D-PCT (3D group), and the rest, by free-hand puncture combined with CT-guided 125Ⅰ seed implantation (free-hand group). During two days before the surgery, the patients received the CT scan. Then the digital imaging and communications in medicine(DICOM) was collected to input to the Brachytherapy Treatment Planning System(BTPS). The dose parameters including D90, D100,V100, V150, conformal index(CI), external index(EI),and homogneneity index(HI) were compared between pre-operation and post-operation. Pair t-test and single sample t-test were performed. Results V150 in 3D group between preoperation and postoperation showed statistically significant difference(t=-2.916, P< 0.05), and there was no significant difference in the rest parameters(P> 0.05). However, the number of seeds, V100, EI, HI in free-hand group between preoperation and postoperation showed statistically significant difference(t=-2.516, 2.492, 4.725, 7.258, P< 0.05), and there was no significant difference in the rest parameters(P> 0.05). Comparison of indicuted that there was significant difference in V100, V150, CI, EI, HI and dose error rate between the 3D group and the free-hand group with single sample t test,the result showed V100, CI, EI, HI between two groups(t=2.598, 2.278, 4.637, 4.616, -4.785, P< 0.05),and there was no significant difference in V150 (P> 0.05). Conclusions CT-guided 125Ⅰ seed implantation brachytherapy combined with 3D-PCT for treatment of NSCLC safe is feasible, and dose controllable, and there is a certain advantage in the spatial distribution of seed compared with free-hand puncture. |
| HTML 查看全文 查看/发表评论 下载PDF阅读器 |
| 关闭 |
|
|
|